HFA Premium Access

A novel oral partial adenosine A1 receptor agonist for the treatment of heart failure: safety and tolerability in healthy volunteers pretreated with beta-blocker

Congress Presentation

About the speaker

Doctor Wilfried Dinh

Bayer Pharmaa AG, Wuppertal (Germany)
0 follower

9 more presentations in this session

Efficacy of trimetazidine on functional capacity in symptomatic patients with moderately reduced or left ventricular dysfunction and CAD: a subgroup analysis of the VASCO trial


Pharmacological treatment of chronic heart failure during cardiac resynchronization therapy

Speaker: Doctor J. Laukaitiene (Kaunas, LT)


Effect of levosimendan on left and right ventricular function in patients with acute and chronic heart failure: a review of echocardiographic studies

Speaker: Associate Professor M. Cameli (Siena, IT)


Two drugs comparasion of bisoprolol in efficiency influence on the heart rate from a position of pharmacoeconomics


How many patients with chronic heart failure will be eligible for LCZ696 in the community?

Speaker: Doctor P. Pellicori (Glasgow, GB)


Access the full session

Poster Session 2 - Drug therapy, other

Speakers: Doctor W. Dinh, Doctor J. Laukaitiene, Associate Professor M. Cameli, Doctor P. Pellicori

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb